ICL Group Ltd (ICL.TA)
| Previous Close | 1,706.00 |
| Open | 1,725.00 |
| Bid | 1,761.00 x 20100 |
| Ask | 1,135.00 x 1591600 |
| Day's Range | 1,700.00 - 1,737.00 |
| 52 Week Range | 1,629.00 - 2,480.00 |
| Volume | |
| Avg. Volume | 1,972,956 |
| Market Cap | 22.4B |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | 9.24 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.70 (4.08%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Business Wire
ICL Announces First Quarter 2024 Earnings Call
TEL AVIV, Israel, April 15, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2024 results prior to the opening of the TASE market on Thursday, May 9, 2024.
- Business Wire
ICL Files 2023 Annual Report on Form 20-F
TEL AVIV, Israel, March 14, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint.
- Business Wire
ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition
TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately $30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL’s product offerings and positioning the company for further expansions into new and adjacent end-markets.
